Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hanabuchi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Ryumachi. [Rheumatism]|April 1, 1994
[Cytotoxicity and apoptosis]K Okumura, S Hanabuchi, H Yagita
Immunological Reviews|August 1, 1995
Fas-mediated cytotoxicity--a new immunoregulatory and pathogenic function of Th1 CD4+ T cellsH Yagita, S Hanabuchi, Y Asano, et al.
Journal of the National Cancer Institute|December 6, 2001
Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunityS Hanabuchi, T Ohashi, Y Koya, et al.
AIDS Research and Human Retroviruses|November 18, 2000
Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative diseaseM Kannagi, T Ohashi, S Hanabuchi, et al.
Journal of Virology|August 8, 1998
Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult ratsH Kato, Y Koya, T Ohashi, et al.
Journal of Virology|December 10, 1999
Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockadeS Hanabuchi, T Ohashi, Y Koya, et al.
Journal of Virology|June 11, 1999
Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cellsT Ohashi, S Hanabuchi, H Kato, et al.
Journal of Virology|July 10, 1999
Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing TaxY Koya, T Ohashi, H Kato, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicityS Hanabuchi, M Koyanagi, A Kawasaki, et al.
Journal of Virology|September 23, 2000
Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccineT Ohashi, S Hanabuchi, H Kato, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Ryumachi. [Rheumatism]|April 1, 1994
[Cytotoxicity and apoptosis]K Okumura, S Hanabuchi, H Yagita
Immunological Reviews|August 1, 1995
Fas-mediated cytotoxicity--a new immunoregulatory and pathogenic function of Th1 CD4+ T cellsH Yagita, S Hanabuchi, Y Asano, et al.
Journal of the National Cancer Institute|December 6, 2001
Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunityS Hanabuchi, T Ohashi, Y Koya, et al.
AIDS Research and Human Retroviruses|November 18, 2000
Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative diseaseM Kannagi, T Ohashi, S Hanabuchi, et al.
Journal of Virology|August 8, 1998
Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult ratsH Kato, Y Koya, T Ohashi, et al.
Journal of Virology|December 10, 1999
Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockadeS Hanabuchi, T Ohashi, Y Koya, et al.
Journal of Virology|June 11, 1999
Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cellsT Ohashi, S Hanabuchi, H Kato, et al.
Journal of Virology|July 10, 1999
Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing TaxY Koya, T Ohashi, H Kato, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicityS Hanabuchi, M Koyanagi, A Kawasaki, et al.
Journal of Virology|September 23, 2000
Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccineT Ohashi, S Hanabuchi, H Kato, et al.
Pageof 2